GI & Endoscopy

Here are three updates on GI companies from the past week:

A study, published in JAMA, examined how providing physicians with lists of nonadherent patients impacted fecal immunochemical test and colorectal cancer screening participation.

A study, published in JAMA, examined which strategy was most effective in promoting colorectal cancer screening among individuals who were not current with their screening.

New Brunswick-based Rutgers Cancer Institute of New Jersey appointed H. Richard Alexander, MD, its new chief surgical officer.

Mark Cossentino, MD, is a gastroenterologist at Endoscopy Center of El Paso (Texas).

Endoscopy Center of El Paso (Texas) has served the El Paso area and its surrounding communities for more than a decade.

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Aug. 28 to Sept. 1, 2017.

Takeda CEO Christophe Weber reaffirmed the company's commitment to globalizing its brand and products amid struggling fiscal year 2017 sales, CNBC reports.

A study, published in Clinical Gastroenterology and Hepatology, examined the cost effectiveness of the Cytosponge, a minimally invasive gastroesophageal reflux disease screening tool.

Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of Aug. 28 to Sept. 1, 2017